Comment
doi: 10.1016/S0140-6736(15)00304-9.
Epub 2015 Sep 27.
Management of late-life depression: a major leap forward
Affiliations
- PMID: 26423179
- DOI: 10.1016/S0140-6736(15)00304-9
Item in Clipboard
Comment
Management of late-life depression: a major leap forward
Lancet.
.
No abstract available
Comment on
-
Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial.Lancet. 2015 Dec 12;386(10011):2404-12. doi: 10.1016/S0140-6736(15)00308-6. Epub 2015 Sep 27. Lancet. 2015. PMID: 26423182 Free PMC article. Clinical Trial.
Similar articles
-
Use of Ketamine in Elderly Patients with Treatment-Resistant Depression.Curr Psychiatry Rep. 2017 Nov 15;19(12):107. doi: 10.1007/s11920-017-0855-x. Curr Psychiatry Rep. 2017. PMID: 29138992 Review.
-
ACP Journal Club. In older adults with treatment-resistant depression, adding aripiprazole to venlafaxine increased remission at 12 wk.Ann Intern Med. 2016 Jan 19;164(2):JC10. doi: 10.7326/ACPJC-2016-164-2-010. Ann Intern Med. 2016. PMID: 26784490 No abstract available.
-
Predictors and Moderators of Remission With Aripiprazole Augmentation in Treatment-Resistant Late-Life Depression: An Analysis of the IRL-GRey Randomized Clinical Trial.JAMA Psychiatry. 2016 Apr;73(4):329-36. doi: 10.1001/jamapsychiatry.2015.3447. JAMA Psychiatry. 2016. PMID: 26963689 Free PMC article. Clinical Trial.
-
The Role of Anger/Hostility in Treatment-Resistant Depression: A Secondary Analysis From the ADAPT-A Study.J Nerv Ment Dis. 2015 Oct;203(10):762-8. doi: 10.1097/NMD.0000000000000364. J Nerv Ment Dis. 2015. PMID: 26348584 Clinical Trial.
-
[MAO-inhibitors--a treatment option for treatment resistant depression: application, efficacy and characteristics].Fortschr Neurol Psychiatr. 2014 Apr;82(4):228-36; quiz 237-8. doi: 10.1055/s-0034-1365945. Epub 2014 Apr 7. Fortschr Neurol Psychiatr. 2014. PMID: 24710679 Review. German. No abstract available.
Cited by
-
Luteolin alleviates depression-like behavior by modulating glycerophospholipid metabolism in the hippocampus and prefrontal cortex of LOD rats.CNS Neurosci Ther. 2024 Mar;30(3):e14455. doi: 10.1111/cns.14455. Epub 2023 Sep 16. CNS Neurosci Ther. 2024. PMID: 37715585 Free PMC article.
-
Association of Cardiovascular Health With Risk of Clinically Relevant Depressive Symptoms.JAMA Psychiatry. 2023 Apr 1;80(4):342-349. doi: 10.1001/jamapsychiatry.2022.5056. JAMA Psychiatry. 2023. PMID: 36790776 Free PMC article.
-
Use of Ketamine in Elderly Patients with Treatment-Resistant Depression.Curr Psychiatry Rep. 2017 Nov 15;19(12):107. doi: 10.1007/s11920-017-0855-x. Curr Psychiatry Rep. 2017. PMID: 29138992 Review.
-
Vascular depression consensus report - a critical update.BMC Med. 2016 Nov 3;14(1):161. doi: 10.1186/s12916-016-0720-5. BMC Med. 2016. PMID: 27806704 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
